A new drug that slows the progression of ALS is exorbitantly expensive, one again raising anger at the pharmaceutical industry for locking life-changing drugs behind high costs.
A new drug that slows the progression of ALS is exorbitantly expensive, one again raising anger at the pharmaceutical industry for locking life-changing drugs behind high costs.